Cancer Research Institute

In 2002, the National Cancer Institute (NCI) awarded St. Vincent Hospital the Community Clinical Oncology Program (CCOP) designation for our excellence in cancer research—one of only 63 sites nationally. In 2014, that connection to the National Cancer Institute continued under their new program—NCI Community Oncology Research Program (NCORP). HSHS St. Vincent Cancer Research Institute works collaboratively with two other health care organizations in Wisconsin (Marshfield Clinic Research Foundation in Marshfield and Gundersen Medical Foundation in LaCrosse) to form the WiNCORP network.

Among the services the HSHS St. Vincent Cancer Research Institute provides:

  • Access to new treatment protocols and drugs for people who have been diagnosed with certain types of cancer
  • Prevention studies to help people remain cancer-free
  • Opportunities for local people to directly contribute to the body of knowledge scientists need to find a cure for cancer
Research sites include any HSHS St. Vincent Hospital Cancer Centers location (Green Bay, Oconto Falls, Marinette and Sturgeon Bay), or affiliates at Holy Family Memorial Cancer Care Center in Manitowoc, HSHS St. Nicholas Hospital Sheboygan and Green Bay Oncology at their satellite locations in the Upper Peninsula of Michigan.

Participation in the cancer clinical trials benefits patients and physicians in the community as well as scientists in research centers. It not only brings the latest research findings directly to our community, but it also increases the number of patients and physicians who take part in clinical trials, which allows scientists to find and bring new treatments forward at a faster rate.

For information about current cancer clinical trials call: (920) 433-8889.


HSHS St. Vincent Cancer Research Institute Team Receives Awards for Clinical Trials

HSHS St. Vincent Cancer Research Institute and Green Bay Oncology physicians, as part of HSHS St. Vincent Hospital Cancer Centers received awards from the National Cancer Institute (NCI).   

The NCI Community Oncology Research Program (NCORP) awarded recognition to physicians in August, recognizing their exceptional efforts in enrolling qualified patients in cancer clinical trials.

Dr. Brian Burnette received the gold award with more than 30 enrollments. Dr. Anthony Jaslowski, Dr. Matthew Ryan, Dr. Sigurdur Bodvarsson and Dr. Ruth Warren each received the silver award for 20-29 enrollments, demonstrating their exceptional commitment to advancing cancer care.

Clinical trials are critical to the advancements in cancer treatments.   Although significant progress has been made in early diagnosis of cancer and in cancer treatment, there continues to be a large unmet need for many types of cancers.  Clinical trials provide patients with access to emerging therapies while also helping to provide data needed to improve cancer care and survival overall.

Nationally, approximately 2-4% of cancer patients participate in clinical trials.  At the HSHS St. Vincent Hospital Cancer Centers, we have enrolled from 13% 21% of patients annually in the past five years.   This is due to the large number of clinical trial opportunities we offer, along with our oncologists’ unwavering commitment to provide patients with the most advanced options available.

NCORP is a national NCI-supported network that brings cancer prevention clinical trials and cancer care delivery research to people throughout the nation.  The NCI funds approximately half of all cancer clinical trials nationally.  

At HSHS St. Vincent Hospital Cancer Centers, we continually strive at being a national leader in improving cancer care for all patients.  Congratulations to the HSHS St. Vincent Cancer Research Institute and physicians for their stellar efforts in providing the best possible care to our patients. 

Brian Burnette, MD – “I feel privileged to have received this gold award, but it is the world-class clinical research team that work with our patients each and every day that are truly deserving. This clinical research program continues to provide our patients with opportunities and treatments that are otherwise unavailable in communities our size.”

Sigurdur Bodvarsson, MD – “I appreciate all the help from the patients who participated in the clinical trials. They are moving the field of oncology forward and improving treatments for all.”

Anthony Jaslowski, MD, FACP – “It’s a pleasure working with dedicated research staff.  I am very excited to be able to offer cutting edge research to our patients.  The patients are the real heroes, and I look up to them. Their participation will hopefully answer the questions in the future on the best treatment approaches.”

Matthew Ryan, MD – “I am quite honored, but the real credit goes to the patients that participated and our research team that do the real work. Without a commitment to research, we will never improve upon our current treatments.”

Ruth Warren, DO – “I am very proud to be part of a team that brings cutting edge medical care and clinical trials to our patients in Northeast Wisconsin.”

Notice of Nondiscrimination::  English

Language Assistance:  Español | Hmoob | Deutsch | Français | 繁體中文 | Deitsch | Polski | العربية | Русский | Italiano | Tagalog | हिंदी  | ພາສາລາວ | 한국어 | Tiếng Việt | اُردُو |